ARCHŌ ELAVAY
908.399.0284 Book 1:1 With Matt

ELAVAY 2025/26 · Oncology Report

Oncology Advocates Rated The Companies They Work With. Act On What They Asked For.

The ELAVAY Oncology report shows where Patient advocacy organizations see industry support meeting their needs and where it falls short, section by section, on a 7-point scale where 4.0 marks the industry average.

Since 2015ELAVAY fielding 7-point scale4.0 industry average OncologyDisease-state cut

Request The Oncology Briefing

Matt Toresco follows up by email to set it up.

Or book a time now: 1:1 with Matt Toresco.

We use your details to send what you asked for. See our privacy policy.

Three Industry-Level Themes

5.30Oncology advocates rate access to company leadership lowest of every relationship attribute, out of 7.Industry levelELAVAY 2026, oncology cut
+1.93Systemic barriers to equity show the widest gap between what oncology advocates want and what industry supports.Industry levelELAVAY 2026, oncology cut
30 of 30program areas show advocacy interest above industry support, across all respondents.Industry levelELAVAY 2026, all respondents

Industry-level findings only. No company scores or ranks appear on this page. Each company sees its own findings in private.

What The Report Covers

Advocates Grade The Relationship. Section By Section.

Advocates rank up to five pharma or biotech companies they worked with in the last 12 to 18 months, then rate their top three on a 1 to 7 scale.

  • Partnerships and Programs Support
  • Federal and State Government Policy
  • Corporate Image and Reputation
  • Contribution to Health Equity
  • Patient Assistance Programs
  • Scale of Selflessness
  • Expanding Access and Education
  • Diversity, Equity and Inclusion

What Teams Do With It

Hear The Community. Change A Decision. Show The Business What It Earned.

Hear

Know Where You Stand

See which sections oncology advocates rate above the 4.0 industry average and where they want more.

Decide

Bring Advocates Into The Plan

Carry the gaps advocates named into program, policy and access plans before the next budget locks.

Earn

Show What Changed

Report what you learned, why it matters to the business and what changed as a result.

More ELAVAY 2025/26 Reports

Four More Reports. One Method.

Disease state

Immunology

Disease state

Mental Health

Disease state

Rare Disease

Syndicated

Annual Report

Next Step

See The Themes. Then Test Your Own Function.

Take the Advocacy Influence Diagnostic to see whether Patient insight changes decisions at your company, then bring the readout to a 1:1 with Matt.

Take The Diagnostic Book 1:1 With Matt